These results indicate Kras + HPV + SONIC-induced tumors can be effectively controlled by vaccination, with tumor regression correlated to a robust HPV16 E7-specific CD8 T cell response, demonstrating the potential of this model for evaluating immunotherapeutic strategies. Here, KRAS is linked to neoplasm.